Atrial in Medical Technology
Navigation Links
Atrial in Medical Technology
... insights into why patients with non-valvular atrial fibrillation (AF) receiving edoxaban once daily ... Phase III trial for edoxaban in patients with atrial fibrillation. The Phase III study, Effective Anticoagulation with Factor Xa Next Generation in atrial Fibrillation (ENGAGE-AF), is comparing edoxaban ...
... to treat a type of irregular heartbeat known as atrial fibrillation. The new comparative effectiveness ... reduces the chance that patients will experience atrial fibrillation over the long term. The ... on stroke, a major risk for patients with atrial fibrillation, is unknown. Radiofrequency catheter ...
... therapy, in patients with non-valvular atrial fibrillation. The results will be unveiled at ... to warfarin in the management of patients with atrial fibrillation. We are looking forward to the ... warfarin therapy for patients with non-valvular atrial fibrillation. Patients ...
... or death by 24 percent in patients with atrial fibrillation - PARIS, Feb. 11 ... (31.9% vs. 39.4%, p<0.001) in patients with atrial fibrillation (AF)/atrial flutter (AFL) or a recent history of these conditions. atrial fibrillation is the leading cause of ...
... major orthopedic surgery; in patients with atrial fibrillation; and in patients with deep-vein ... elevate a person's risk of clotting, including atrial fibrillation (an abnormal heart rhythm), previous ... With Warfarin in Subjects With Non-Valvular atrial Fibrillat i on [Abstract #33] ...
... regimens of DU-176b in patients with non-valvular atrial fibrillation (AF), as compared to warfarin. ... Study A total of 1,146 patients with atrial fibrillation with a CHADS2 index >/= 2 were ... endpoints across treatment groups. About atrial Fibrillation ...
... oral Factor Xa inhibitor, in patients with atrial fibrillation. DU-176b is being developed solely ... Anticoagulation with Factor Xa Next Generation in atrial Fibrillation (ENGAGE-AF TIMI 48), will compare ... systemic embolic events (SEE) in patients with atrial fibrillation. The primary safety assessment will ...
... number of hospital days by 28% in patients with atrial fibrillation or flutter NEW ORLEANS, Nov. 11 ... Dronedarone also decreased mean heart rate during atrial fibrillation to 78 beats per minute, compared ... (p<0.001). Fewer patients developed permanent atrial fibrillation during the study in the dronedarone ...
... for a new device to treat persistent atrial fibrillation. TCAI, an international treatment, ... the nation in pioneering new treatments for atrial fibrillation," Dr. Rodney ... more than two million people nationwide. atrial fibrillation, or A Fib, is the most common ...
... the risk of stroke by 34% in patient with atrial fibrillation or atrial flutter already adequately treated ... (46 vs 70 stroke events respectively; p=0.027) in atrial fibrillation ...
... the Risk of Stroke by 34% in Patients With atrial Fibrillation or atrial Flutter Already Adequately Treated by ... (46 vs 70 stroke events respectively; p=0.027) in atrial fibrillation ...
... with paroxysmal atrial fibrillation. Paroxysmal atrial fibrillation (PAF) is characterized by a rapid ... anti-arrhythmic drug therapy and were free of atrial fibrillation 9 months (+/- 2 months) following ... finding, since so many patients with paroxysmal atrial fibrillation are visiting their healthcare ...
... for the first time in patients with permanent atrial fibrillation, that dronedarone (Multaq(R)) ... to cardioversion) or permanent (continuous atrial fibrillation with cardioversion proven or deemed ... for the cOntrol of ventricular rate during atrial fibrillation), a randomised, double ...
... reporting positive findings about its novel atrial fibrillation catheter ablation system were ... targets called CFAEs (Complex Fractionated atrial Electrograms). Six month follow up data was ... procedure rate of 13.5% and the absence of left atrial flutters after the procedure. "These early ...
... using the advanced ablation system to treat atrial fibrillation (AF) patients in commercial ... the paroxysmal and permanent AF populations." atrial Fibrillation is a common and devastating cardiac ... dedicated to helping individuals suffering from atrial fibrillation and other cardiac arrhythmias. ...
... therapy for the treatment of patients with atrial fibrillation or atrial flutter, decreased the risk of cardiovascular ... and antithrombotic drugs, in patients with atrial fibrillation ...
... Heart Association. In the study, known as the atrial arrhythmia Conversion Trial (ACT I), the primary ... (51.7%) KYNAPID patients in the short-duration atrial fibrillation (AF) group (3 hours to 7 days) ... patients with symptomatic AF or nontypical atrial flutter, conducted at 44 sites in Canada, the ...
... Dr. James L. Cox in the 1980s to treat atrial fibrillation (AF) with a high rate of long-term ... procedure, 54 of these patients had continuous atrial Fibrillation, the most difficult type of AF to ... 50 million patients worldwide who suffer from atrial fibrillation." Development Update As ...
... of stroke and systemic embolism in patients with atrial fibrillation. RE-LY (Randomized Evaluation of ... Therapy) is the largest stroke prevention in atrial fibrillation trial conducted to date, with ... INR 2.0-3.0) in patients with non-valvular atrial fibrillation who are at moderate-to-high risk ...
... rhythm (sinus rhythm, or SR) in patients with atrial fibrillation (AF) following coronary artery ... CABG or valvular surgeries." Study Results The atrial arrhythmia Conversion Trial or ACT II was a ... vernakalant among patients who experienced AF or atrial flutter within 24 hours to 7 days after ...
... rhythm (sinus rhythm, or SR) in patients with atrial fibrillation (AF) treated within 48 hours of the ... Study Results The study, referred to as the atrial arrhythmia conversion trial or ACT I, was a ... of patients with symptomatic AF or nontypical atrial flutter, conducted at 44 sites in Canada, the ...
... pulmonary vein isolation for the treatment of atrial fibrillation. The Endoscopic Ablation System has ... the most common heart rhythm disturbance called atrial fibrillation, a disease affecting more than 5 ... the potential for aiding patients afflicted with atrial fibrillation worldwide," said Stephen Sagon the ...
... three Phase I studies completed in China, HBI-3000 was well tolerated. atrial Fibrillation (AF) is a serious type of arrhythmia found in approximately ... is initially being developed and investigated for use as IV treatment of atrial fibrillation with clinical trials expected to begin in early 2009. "This ...
... coverage expands to include those on anticoagulant medication with chronic atrial fibrillation and venous thromboembolism. "The decision to expand ... . About Anticoagulation Monitoring Certain patients with atrial fibrillation, a mechanical heart valve or deep vein thrombosis require ...
... of Montreal and Principal Investigator of the recently completed atrial Fibrillation and Congestive Heart Failure multi-center international ... and heart failure. A large subset of individuals with atrial and ventricular arrhythmias suffers from these conditions, precluding ...
... activity. HBI-3000 is being developed as a potential treatment for both atrial and ventricular arrhythmias. Anti-arrhythmic drugs are used today to ... and heart failure. A large subset of individuals with atrial and ventricular arrhythmias suffers from these conditions, precluding ...
... action from the FDA on or before January 19, 2008. About atrial Fibrillation atrial fibrillation (AFib) is an abnormal heart rhythm, known as a cardiac ...
... are encouraged by the data demonstrating bucindolol's effect in preventing atrial fibrillation and life threatening ventricular arrhythmia, showing the ... highest priority for treatment with bucindolol. New Data on Bucindolol in atrial Fibrillation and Ventricular Arrhythmia Data from the Phase 3 BEST ...
... of dosing in a Phase 1 clinical trial of PL-3994, a long acting analog of atrial natriuretic peptide, under development for treatment of acute ... older than 65 years of age and an underserved medical condition." atrial natriuretic peptide (ANP) is a naturally produced peptide hormone involved ...
... safety parameters, including kidney and cardiovascular safety (including atrial fibrillation), found Reclast to be comparable with placebo. Incidence of ... between the Reclast and placebo group (6.2% versus 5.6%, respectively). atrial fibrillation serious adverse events occurred in 1.1% of Reclast-treated ...
... to treat a type of irregular heartbeat known as atrial fibrillation. The new comparative effectiveness ... reduces the chance that patients will experience atrial fibrillation over the long term. The ... on stroke, a major risk for patients with atrial fibrillation, is unknown. Radiofrequency catheter ...
FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone)
... (FDA) to treat patients with non-permanent atrial fibrillation (AF). As demonstrated in the ... in morbidity and mortality in patients with atrial fibrillation/atrial flutter (AFL) or a recent ... when reviewing new drug applications. atrial fibrillation is the leading cause of ...... therapy, in patients with non-valvular atrial fibrillation. The results will be unveiled at ... to warfarin in the management of patients with atrial fibrillation. We are looking forward to the ... warfarin therapy for patients with non-valvular atrial fibrillation. Patients ...
... or death by 24 percent in patients with atrial fibrillation - PARIS, Feb. 11 ... (31.9% vs. 39.4%, p<0.001) in patients with atrial fibrillation (AF)/atrial flutter (AFL) or a recent history of these conditions. atrial fibrillation is the leading cause of ...
... major orthopedic surgery; in patients with atrial fibrillation; and in patients with deep-vein ... elevate a person's risk of clotting, including atrial fibrillation (an abnormal heart rhythm), previous ... With Warfarin in Subjects With Non-Valvular atrial Fibrillat i on [Abstract #33] ...
... regimens of DU-176b in patients with non-valvular atrial fibrillation (AF), as compared to warfarin. ... Study A total of 1,146 patients with atrial fibrillation with a CHADS2 index >/= 2 were ... endpoints across treatment groups. About atrial Fibrillation ...
... oral Factor Xa inhibitor, in patients with atrial fibrillation. DU-176b is being developed solely ... Anticoagulation with Factor Xa Next Generation in atrial Fibrillation (ENGAGE-AF TIMI 48), will compare ... systemic embolic events (SEE) in patients with atrial fibrillation. The primary safety assessment will ...
... number of hospital days by 28% in patients with atrial fibrillation or flutter NEW ORLEANS, Nov. 11 ... Dronedarone also decreased mean heart rate during atrial fibrillation to 78 beats per minute, compared ... (p<0.001). Fewer patients developed permanent atrial fibrillation during the study in the dronedarone ...
... for a new device to treat persistent atrial fibrillation. TCAI, an international treatment, ... the nation in pioneering new treatments for atrial fibrillation," Dr. Rodney ... more than two million people nationwide. atrial fibrillation, or A Fib, is the most common ...
... the risk of stroke by 34% in patient with atrial fibrillation or atrial flutter already adequately treated ... (46 vs 70 stroke events respectively; p=0.027) in atrial fibrillation ...
... the Risk of Stroke by 34% in Patients With atrial Fibrillation or atrial Flutter Already Adequately Treated by ... (46 vs 70 stroke events respectively; p=0.027) in atrial fibrillation ...
... with paroxysmal atrial fibrillation. Paroxysmal atrial fibrillation (PAF) is characterized by a rapid ... anti-arrhythmic drug therapy and were free of atrial fibrillation 9 months (+/- 2 months) following ... finding, since so many patients with paroxysmal atrial fibrillation are visiting their healthcare ...
... for the first time in patients with permanent atrial fibrillation, that dronedarone (Multaq(R)) ... to cardioversion) or permanent (continuous atrial fibrillation with cardioversion proven or deemed ... for the cOntrol of ventricular rate during atrial fibrillation), a randomised, double ...
Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation
... cause in patients with Atrial Fibrillation." atrial fibrillation is a major cause of hospitalization ... including congestive heart failure. Furthermore atrial fibrillation considerably impairs patients' ... investigational new treatment for patients with atrial fibrillation, which has been discovered ...... reporting positive findings about its novel atrial fibrillation catheter ablation system were ... targets called CFAEs (Complex Fractionated atrial Electrograms). Six month follow up data was ... procedure rate of 13.5% and the absence of left atrial flutters after the procedure. "These early ...
... using the advanced ablation system to treat atrial fibrillation (AF) patients in commercial ... the paroxysmal and permanent AF populations." atrial Fibrillation is a common and devastating cardiac ... dedicated to helping individuals suffering from atrial fibrillation and other cardiac arrhythmias. ...
ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
... press conference entitled, "New Perspectives in atrial Fibrillation Management" chaired by John Camm, ... results, on the potential management of atrial fibrillation, a common form of cardiac ... marks a paradigm change for the management of atrial fibrillation," said Prof Christopher Cannon, a ...ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
... press conference entitled "New Perspectives in atrial Fibrillation Management" chaired by John ... marks a paradigm change for the management of atrial fibrillation," said Prof Christopher Cannon, a ... may become a first line treatment of atrial fibrillation." The ATHENA study results were ...... therapy for the treatment of patients with atrial fibrillation or atrial flutter, decreased the risk of cardiovascular ... and antithrombotic drugs, in patients with atrial fibrillation ...
... Heart Association. In the study, known as the atrial arrhythmia Conversion Trial (ACT I), the primary ... (51.7%) KYNAPID patients in the short-duration atrial fibrillation (AF) group (3 hours to 7 days) ... patients with symptomatic AF or nontypical atrial flutter, conducted at 44 sites in Canada, the ...
... Dr. James L. Cox in the 1980s to treat atrial fibrillation (AF) with a high rate of long-term ... procedure, 54 of these patients had continuous atrial Fibrillation, the most difficult type of AF to ... 50 million patients worldwide who suffer from atrial fibrillation." Development Update As ...
... of stroke and systemic embolism in patients with atrial fibrillation. RE-LY (Randomized Evaluation of ... Therapy) is the largest stroke prevention in atrial fibrillation trial conducted to date, with ... INR 2.0-3.0) in patients with non-valvular atrial fibrillation who are at moderate-to-high risk ...
FDA Grants Approval to Extend U.S. Enrollment and Clinical Trial
... Uses Novel Technology in Treatment of Chronic atrial Fibrillation Patients ... trial for interventional treatment of chronic atrial fibrillation (AF). Approval from the US Food and ... the time it takes to complete complex left atrial procedures. Second, the depth of the ...Positive Results Published Using AtriCure Minimally Invasive Products
... products, which physicians have adopted to treat atrial fibrillation (AF), were published in The Annals ... Additionally, in 21 of the 22 patients, the left atrial appendage was removed. Of the 22 symptomatic, ... block the abnormal electrical impulses that cause atrial fibrillation, or AF, a rapid, irregular quivering ...... rhythm (sinus rhythm, or SR) in patients with atrial fibrillation (AF) following coronary artery ... CABG or valvular surgeries." Study Results The atrial arrhythmia Conversion Trial or ACT II was a ... vernakalant among patients who experienced AF or atrial flutter within 24 hours to 7 days after ...
... rhythm (sinus rhythm, or SR) in patients with atrial fibrillation (AF) treated within 48 hours of the ... Study Results The study, referred to as the atrial arrhythmia conversion trial or ACT I, was a ... of patients with symptomatic AF or nontypical atrial flutter, conducted at 44 sites in Canada, the ...
Atritech Announces Completion of a $22 Million Equity Financing
... potentially causing a stroke. Patients with atrial fibrillation (a heart condition which causes the ... Inc. relating to closure devices within the left atrial appendage. This acquisition of over 60 patents ... Company as the clear leader in the left atrial appendage closure market. "The recent ...CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
... its pivotal clinical study for the treatment of atrial fibrillation. Ed Brennan, Ph.D. Chief Executive ... confirms our lead over other companies conducting atrial fibrillation ablation pivotal trials and ... our product to market for the treatment of atrial fibrillation. With the recent approval of ...... pulmonary vein isolation for the treatment of atrial fibrillation. The Endoscopic Ablation System has ... the most common heart rhythm disturbance called atrial fibrillation, a disease affecting more than 5 ... the potential for aiding patients afflicted with atrial fibrillation worldwide," said Stephen Sagon the ...
CryoCor Receives FDA Approval for Right Atrial Flutter
... Cryoablation System for the treatment of right atrial flutter. Based on this approval, CryoCor intends ... Cryoablation System for the treatment of right atrial flutter. There is a large opportunity for ... is a less painful way of ablating right atrial flutter as demonstrated by several published ...... three Phase I studies completed in China, HBI-3000 was well tolerated. atrial Fibrillation (AF) is a serious type of arrhythmia found in approximately ... is initially being developed and investigated for use as IV treatment of atrial fibrillation with clinical trials expected to begin in early 2009. "This ...
... coverage expands to include those on anticoagulant medication with chronic atrial fibrillation and venous thromboembolism. "The decision to expand ... . About Anticoagulation Monitoring Certain patients with atrial fibrillation, a mechanical heart valve or deep vein thrombosis require ...
Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home
... coverage expands to include those on anticoagulant medication with chronic atrial fibrillation and venous thromboembolism. "This expanded coverage will ... . About Anticoagulation Monitoring Certain patients with atrial fibrillation, a mechanical heart valve or deep vein thrombosis require ...... of Montreal and Principal Investigator of the recently completed atrial Fibrillation and Congestive Heart Failure multi-center international ... and heart failure. A large subset of individuals with atrial and ventricular arrhythmias suffers from these conditions, precluding ...
... activity. HBI-3000 is being developed as a potential treatment for both atrial and ventricular arrhythmias. Anti-arrhythmic drugs are used today to ... and heart failure. A large subset of individuals with atrial and ventricular arrhythmias suffers from these conditions, precluding ...
... action from the FDA on or before January 19, 2008. About atrial Fibrillation atrial fibrillation (AFib) is an abnormal heart rhythm, known as a cardiac ...
... are encouraged by the data demonstrating bucindolol's effect in preventing atrial fibrillation and life threatening ventricular arrhythmia, showing the ... highest priority for treatment with bucindolol. New Data on Bucindolol in atrial Fibrillation and Ventricular Arrhythmia Data from the Phase 3 BEST ...
... of dosing in a Phase 1 clinical trial of PL-3994, a long acting analog of atrial natriuretic peptide, under development for treatment of acute ... older than 65 years of age and an underserved medical condition." atrial natriuretic peptide (ANP) is a naturally produced peptide hormone involved ...
... safety parameters, including kidney and cardiovascular safety (including atrial fibrillation), found Reclast to be comparable with placebo. Incidence of ... between the Reclast and placebo group (6.2% versus 5.6%, respectively). atrial fibrillation serious adverse events occurred in 1.1% of Reclast-treated ...
Other ContentsbalancedbalancedbalancedbalancedbalancedbalancedbalancedbalancedbalancedbehaviorbehaviorbehaviorbehaviorbehaviorbehaviorbehaviorbehaviorbariumbariumbarotraumabasalbasalbasalbasalbasalbasalbasalbasaltrunktrunktrunktrunkOther TagsClamClamClamopensopensopensCatCatCatCatCatCatCatCatAwayAwayAwayTestedOutOutOutOutOutOutOutOutCoaxwildwildwildPreylikelikelikelikelikeOther Tagsstimulation 2stimulation 3stimulation 4stimulation 5stimulation 6vertebral 2adolescents 2adolescents 3adolescents 4adolescents 5adolescents 6adolescents 7adolescents 8adolescents 9adolescents 10mammogram 2mammogram 3interpretation 2interpretation 3blindness 2advantages 2advantages 3advantages 4advantages 5average 2average 3average 4average 5average 6average 7average 8average 9average 10thinking 2thinking 3thinking 4thinking 5thinking 6
(Date:11/25/2009)... NOVEMBER 25, 2009 Soil is the linchpin of the en...phere meet. Despite that, many students see soil a... more. Soil science educators are challenged with ...ize the critical importance of soil in the environ... and earth science teachers at University of Nebra...
(Date:11/25/2009)...te University assistant professors recently receiv...SF) to continue research beneficial to understandi...0. , Christopher Blackwood, assistant professor ...ded grants to support two separate research projec...er Decomposer Communities and Functions from the L...
(Date:11/24/2009)...s of years it has been prescribed by traditional h... headaches and stomach pain to fever and flu. , N...iversity have been able to scientifically prove th...therwise known as Brazilian mint. , Testing this ...by researcher Graciela Rocha was able to show that...
Breaking Biology News(10 mins):It's not just dirt! 2Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2FertilityAuthority Introduces E Newsletter The Daily Shot 51744 1FertilityAuthority Introduces E Newsletter The Daily Shot 51744 2Snoring Isn 26apos 3Bt Sexy LLC Announces Professional Relationship with the American Sleep Apnea Association 51742 1Snoring Isn 26apos 3Bt Sexy LLC Announces Professional Relationship with the American Sleep Apnea Association 51742 2Marathon Health Adds Fitness Center Capability Medically based Fitness Centers Show Improved Engagement and Efficacy 51739 1Marathon Health Adds Fitness Center Capability Medically based Fitness Centers Show Improved Engagement and Efficacy 51739 2Marathon Health Adds Fitness Center Capability Medically based Fitness Centers Show Improved Engagement and Efficacy 51739 3(Date:11/25/2009)...rchers have found evidence of a statistically sign...mong patients whose estrogen receptor (ER)-positiv...alpha; at serine-118 (ER-alpha S118-P), according ... 25 in the Journal of the National Cancer Institu...e resistant to tamoxifen. Preclinical studies have...
(Date:11/25/2009)...ab, already used to fight rheumatoid arthritis, co... , WEDNESDAY, Nov. 25 (HealthDay News) --...oma and rheumatoid arthritis now also shows some p...pe 1 diabetes. , The drug, rituximab (Rituxan),...insulin, even though the disease had destroyed som...
(Date:11/25/2009)... positive note, CDC sees few signs of trouble with...25 (HealthDay News) -- The ongoing H1N1 swine flu ...s pneumonias among younger patients, a U.S. health...ncrease in serious pneumococcal infections around ...ational Center for Immunization and Respiratory Di...
(Date:11/25/2009)...IDGE, Mass. -- A cancer vaccine carried into the b...plant is the first to successfully eliminate tumor...ournal Science Translational Medicine . , The n...ogists at Harvard University, uses plastic disks i...ted under the skin to reprogram the mammalian immu...
(Date:11/25/2009)...ound puffs of air on flesh that mimicked parts of ...WEDNESDAY, Nov. 25 (HealthDay News) -- People can ...ir skin, new research shows. , In fact, sensati... speech actually helped people decipher sounds bet...never been able to show whether we could use tacti...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |